Inactive Instrument
Phosphagenics Limited Share Price Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 76.61M 52.95M 46.45M 42.88M 39.63M 75.11M 5.07B 515M 200M 2.48B 199M 195M 8.61B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 71.96M 49.74M 43.63M 40.28M 37.22M 70.55M 4.76B 484M 188M 2.33B 187M 183M 8.09B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
76.76% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 30/04/2020 |
Roksan Libinaki
COO | Chief Operating Officer | - | 30/04/2020 |
Naomi Lawrie
SEC | Corporate Secretary | - | 30/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 12/04/2015 |
Gregory Collier
CHM | Chairman | - | 31/12/2018 |
Kathy Connell
BRD | Director/Board Member | 59 | 25/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 52.95M | ||
| -1.60% | +2.02% | +56.34% | +168.94% | 1,084B | ||
| -1.44% | +3.71% | +69.07% | +65.40% | 634B | ||
| -0.75% | +0.67% | +33.18% | +86.52% | 447B | ||
| -0.34% | -2.37% | +28.23% | +25.69% | 330B | ||
| -9.07% | -11.60% | +24.03% | +26.25% | 295B | ||
| -0.55% | -2.31% | +28.20% | +45.79% | 285B | ||
| -1.00% | -3.63% | -27.78% | -39.73% | 218B | ||
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | ||
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | ||
| Average | -2.38% | +2.52% | +28.61% | +58.85% | 406.65B | |
| Weighted average by Cap. | -0.54% | +2.48% | +40.05% | +85.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 783K 687K 634K 586K 1.11M 74.97M 7.62M 2.96M 36.69M 2.94M 2.88M 127M | 1.24M 856K 750K 693K 640K 1.21M 81.92M 8.33M 3.24M 40.09M 3.21M 3.14M 139M |
| Net income | -3.12M -2.16M -1.89M -1.75M -1.61M -3.06M -207M -21.01M -8.16M -101M -8.1M -7.93M -351M | -4.42M -3.05M -2.68M -2.47M -2.28M -4.33M -292M -29.72M -11.55M -143M -11.46M -11.21M -497M |
| Net Debt | -1.3M -897K -787K -726K -671K -1.27M -85.9M -8.73M -3.39M -42.04M -3.37M -3.3M -146M | -4.65M -3.21M -2.82M -2.6M -2.4M -4.56M -308M -31.28M -12.15M -151M -12.07M -11.8M -523M |
Employees
-
Sector
Pharmaceuticals
















